{"transactions":[{"id":730440,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":36322,"kind":"person","name":"Geiger Uri","position":1,"cik":"0001467361","reported_name":"Geiger Uri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-22T20:34:05.000Z","date":"2026-06-19","kind":"grant","planned":false,"acquired":true,"shares":789,"price":15.63,"value":12332.07,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees."}],"balance_after":18537,"source":{"system":"sec-edgar","filing":"0001467361-26-000005","document":"wk-form4_1782160441.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1467361/000146736126000005/wk-form4_1782160441.xml","form_type":"4"}},{"id":747832,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":36322,"kind":"person","name":"Geiger Uri","position":1,"cik":"0001467361","reported_name":"Geiger Uri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T21:10:33.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":5368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable, subject to the Reporting Person's continuous service through each vesting date."}],"balance_after":5368,"derivative":{"exercise_price":15.74,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":5368},"source":{"system":"sec-edgar","filing":"0001467361-26-000003","document":"wk-form4_1780693831.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1467361/000146736126000003/wk-form4_1780693831.xml","form_type":"4"}},{"id":747831,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":36322,"kind":"person","name":"Geiger Uri","position":1,"cik":"0001467361","reported_name":"Geiger Uri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T21:10:33.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":2890,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares shall vest in twelve (12) equal consecutive monthly installments until all of the shares are fully vested, subject to the Reporting Person's continuous service through each vesting date."}],"balance_after":17748,"source":{"system":"sec-edgar","filing":"0001467361-26-000003","document":"wk-form4_1780693831.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1467361/000146736126000003/wk-form4_1780693831.xml","form_type":"4"}},{"id":829199,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":36322,"kind":"person","name":"Geiger Uri","position":1,"cik":"0001467361","reported_name":"Geiger Uri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-24T20:47:17.000Z","date":"2026-03-20","kind":"grant","planned":false,"acquired":true,"shares":913,"price":13,"value":11869.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees."}],"balance_after":14858,"source":{"system":"sec-edgar","filing":"0001628280-26-020837","document":"wk-form4_1774385234.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1467361/000162828026020837/wk-form4_1774385234.xml","form_type":"4"}},{"id":959550,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":36322,"kind":"person","name":"Geiger Uri","position":1,"cik":"0001467361","reported_name":"Geiger Uri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-23T21:15:26.000Z","date":"2025-12-19","kind":"grant","planned":false,"acquired":true,"shares":715,"price":16.59,"value":11861.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees."}],"balance_after":13945,"source":{"system":"sec-edgar","filing":"0001467361-25-000005","document":"form4-12232025_041220.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1467361/000146736125000005/form4-12232025_041220.xml","form_type":"4"}},{"id":1034456,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":36322,"kind":"person","name":"Geiger Uri","position":1,"cik":"0001467361","reported_name":"Geiger Uri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-22T23:30:11.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":1194,"price":9.94,"value":11868.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees."}],"balance_after":13230,"source":{"system":"sec-edgar","filing":"0001467361-25-000003","document":"form4-09222025_070908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1467361/000146736125000003/form4-09222025_070908.xml","form_type":"4"}},{"id":1102597,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":36322,"kind":"person","name":"Geiger Uri","position":1,"cik":"0001467361","reported_name":"Geiger Uri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T20:30:17.000Z","date":"2025-06-21","kind":"grant","planned":false,"acquired":true,"shares":1140,"price":10.41,"value":11867.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees."}],"balance_after":12036,"source":{"system":"sec-edgar","filing":"0001415889-25-018091","document":"form4-06242025_040607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1467361/000141588925018091/form4-06242025_040607.xml","form_type":"4"}},{"id":1102596,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":36322,"kind":"person","name":"Geiger Uri","position":1,"cik":"0001467361","reported_name":"Geiger Uri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T20:30:17.000Z","date":"2025-03-21","kind":"grant","planned":false,"acquired":true,"shares":987,"price":12.02,"value":11863.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees."}],"balance_after":10896,"source":{"system":"sec-edgar","filing":"0001415889-25-018091","document":"form4-06242025_040607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1467361/000141588925018091/form4-06242025_040607.xml","form_type":"4"}},{"id":1102595,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":36322,"kind":"person","name":"Geiger Uri","position":1,"cik":"0001467361","reported_name":"Geiger Uri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T20:30:17.000Z","date":"2024-12-21","kind":"grant","planned":false,"acquired":true,"shares":1029,"price":11.53,"value":11864.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees."}],"balance_after":9909,"source":{"system":"sec-edgar","filing":"0001415889-25-018091","document":"form4-06242025_040607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1467361/000141588925018091/form4-06242025_040607.xml","form_type":"4"}},{"id":1102594,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":36322,"kind":"person","name":"Geiger Uri","position":1,"cik":"0001467361","reported_name":"Geiger Uri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T20:30:17.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":1703,"price":6.97,"value":11869.91,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees."}],"balance_after":8880,"source":{"system":"sec-edgar","filing":"0001415889-25-018091","document":"form4-06242025_040607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1467361/000141588925018091/form4-06242025_040607.xml","form_type":"4"}},{"id":1102593,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":36322,"kind":"person","name":"Geiger Uri","position":1,"cik":"0001467361","reported_name":"Geiger Uri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T20:30:17.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":1570,"price":7.56,"value":11869.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees."}],"balance_after":7177,"source":{"system":"sec-edgar","filing":"0001415889-25-018091","document":"form4-06242025_040607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1467361/000141588925018091/form4-06242025_040607.xml","form_type":"4"}},{"id":1102592,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":36322,"kind":"person","name":"Geiger Uri","position":1,"cik":"0001467361","reported_name":"Geiger Uri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T20:30:17.000Z","date":"2024-03-29","kind":"grant","planned":false,"acquired":true,"shares":899,"price":13.2,"value":11866.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees."}],"balance_after":5607,"source":{"system":"sec-edgar","filing":"0001415889-25-018091","document":"form4-06242025_040607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1467361/000141588925018091/form4-06242025_040607.xml","form_type":"4"}},{"id":1102591,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":36322,"kind":"person","name":"Geiger Uri","position":1,"cik":"0001467361","reported_name":"Geiger Uri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T20:30:17.000Z","date":"2023-12-29","kind":"grant","planned":false,"acquired":true,"shares":1151,"price":10.31,"value":11866.81,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees."}],"balance_after":4708,"source":{"system":"sec-edgar","filing":"0001415889-25-018091","document":"form4-06242025_040607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1467361/000141588925018091/form4-06242025_040607.xml","form_type":"4"}},{"id":1102590,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":36322,"kind":"person","name":"Geiger Uri","position":1,"cik":"0001467361","reported_name":"Geiger Uri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T20:30:17.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":1220,"price":9.73,"value":11870.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees."}],"balance_after":3557,"source":{"system":"sec-edgar","filing":"0001415889-25-018091","document":"form4-06242025_040607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1467361/000141588925018091/form4-06242025_040607.xml","form_type":"4"}},{"id":1102589,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":36322,"kind":"person","name":"Geiger Uri","position":1,"cik":"0001467361","reported_name":"Geiger Uri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T20:30:17.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":2337,"price":4.49,"value":10493.13,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees."}],"balance_after":2337,"source":{"system":"sec-edgar","filing":"0001415889-25-018091","document":"form4-06242025_040607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1467361/000141588925018091/form4-06242025_040607.xml","form_type":"4"}},{"id":1117816,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":36322,"kind":"person","name":"Geiger Uri","position":1,"cik":"0001467361","reported_name":"Geiger Uri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-09T21:26:00.000Z","date":"2025-06-06","kind":"grant","planned":false,"acquired":true,"shares":8745,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable, subject to the Reporting Person's continuous service through each vesting date."}],"balance_after":8745,"derivative":{"exercise_price":13.15,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":8745},"source":{"system":"sec-edgar","filing":"0001415889-25-016326","document":"form4-06092025_050606.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1467361/000141588925016326/form4-06092025_050606.xml","form_type":"4"}},{"id":1452960,"issuer":{"id":72980,"kind":"organization","name":"STRATA Skin Sciences, Inc.","symbol":"SSKN"},"owners":[{"id":36322,"kind":"person","name":"Geiger Uri","position":1,"cik":"0001467361","reported_name":"Geiger Uri","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-17T17:08:57.000Z","date":"2024-07-15","kind":"purchase","planned":false,"acquired":true,"shares":230573,"price":3.14,"value":723999.22,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares are held directly by Accelmed Partners, L.P. The reporting person is the controlling member and managing partner of Accelmed Growth Partners (AGP) Limited, which is the general partner of Accelmed Partners (GP), L.P., which is the general partner of Accelmed Partners, L.P. and as a result he may be deemed to beneficially own the shares of common stock held by Accelmed Partners, L.P. The reporting person is the controlling shareholder and managing partner of Accelmed Growth Partners Management Ltd., which has certain voting and dispositive power over the shares of common stock owned by Accelmed Partners, L.P. pursuant to a management agreement, and as a result the reporting person may be deemed to beneficially own the shares of the common stock held by Accelmed Partners, L.P. The reporting person disclaims such beneficial ownership except to the extent of his pecuniary interest therein."}],"balance_after":1441835,"source":{"system":"sec-edgar","filing":"0001213900-24-062198","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051514/000121390024062198/ownership.xml","form_type":"4"}},{"id":1483376,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":36322,"kind":"person","name":"Geiger Uri","position":1,"cik":"0001467361","reported_name":"Geiger Uri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Rt to Buy)","published_at":"2024-06-11T20:15:49.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":17774,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable."}],"balance_after":17774,"derivative":{"exercise_price":6.47,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":17774},"source":{"system":"sec-edgar","filing":"0001415889-24-016357","document":"form4-06112024_080644.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1467361/000141588924016357/form4-06112024_080644.xml","form_type":"4"}},{"id":1855819,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":36322,"kind":"person","name":"Geiger Uri","position":1,"cik":"0001467361","reported_name":"Geiger Uri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Rt to Buy)","published_at":"2023-06-14T20:58:08.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":27380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable."}],"balance_after":27380,"derivative":{"exercise_price":4.2,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":27380},"source":{"system":"sec-edgar","filing":"0001209191-23-037075","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1467361/000120919123037075/doc4.xml","form_type":"4"}},{"id":2058746,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":36322,"kind":"person","name":"Geiger Uri","position":1,"cik":"0001467361","reported_name":"Geiger Uri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-09T21:30:42.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":120521,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in thirty six (36) equal consecutive monthly installments until all of the option shares are fully vested and exercisable."}],"balance_after":120521,"derivative":{"exercise_price":1.535,"expiration_date":"2033-01-04","underlying":"Common Stock","underlying_shares":120521},"source":{"system":"sec-edgar","filing":"0001209191-23-002565","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1467361/000120919123002565/doc4.xml","form_type":"4"}},{"id":3821141,"issuer":{"id":72980,"kind":"organization","name":"STRATA Skin Sciences, Inc.","symbol":"SSKN"},"owners":[{"id":36322,"kind":"person","name":"Geiger Uri","position":1,"cik":"0001467361","reported_name":"Geiger Uri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"SSKN Common Stock","published_at":"2018-09-10T11:03:03.000Z","date":"2018-06-15","kind":"other","acquired":true,"shares":75590,"price":1.09,"value":82393.1,"ownership":{"direct":false,"nature":"see footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"6/15/18 the reporting person was entitled to receive 75,590 shares of the common stock pursuant to a \"retained risk\" provision in the Securities Purchase Agreement between the Company and Accelmed Growth Partners, L.P. dated 5/29/18 (\"Purchase Agreement\"). Purchase Agreement provided that the purchaser would receive additional shares of common stock in the event of certain contingent expense events, one of which was determined to have occurred on 6/15/18, resulted in the purchaser acquired additional shares. The number of shares issuable pursuant to that provision, determined on 6/15/18 pursuant to a formula set forth in the Purchase Agreement provided that, for purposes of determining the number of shares issuable, the common stock would be valued at $1.09 per share, which was the purchase price of the common stock in the Purchase Agreement."},{"field":"shares","element":"transactionShares","label":"F1","text":"6/15/18 the reporting person was entitled to receive 75,590 shares of the common stock pursuant to a \"retained risk\" provision in the Securities Purchase Agreement between the Company and Accelmed Growth Partners, L.P. dated 5/29/18 (\"Purchase Agreement\"). Purchase Agreement provided that the purchaser would receive additional shares of common stock in the event of certain contingent expense events, one of which was determined to have occurred on 6/15/18, resulted in the purchaser acquired additional shares. The number of shares issuable pursuant to that provision, determined on 6/15/18 pursuant to a formula set forth in the Purchase Agreement provided that, for purposes of determining the number of shares issuable, the common stock would be valued at $1.09 per share, which was the purchase price of the common stock in the Purchase Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"6/15/18 the reporting person was entitled to receive 75,590 shares of the common stock pursuant to a \"retained risk\" provision in the Securities Purchase Agreement between the Company and Accelmed Growth Partners, L.P. dated 5/29/18 (\"Purchase Agreement\"). Purchase Agreement provided that the purchaser would receive additional shares of common stock in the event of certain contingent expense events, one of which was determined to have occurred on 6/15/18, resulted in the purchaser acquired additional shares. The number of shares issuable pursuant to that provision, determined on 6/15/18 pursuant to a formula set forth in the Purchase Agreement provided that, for purposes of determining the number of shares issuable, the common stock would be valued at $1.09 per share, which was the purchase price of the common stock in the Purchase Agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consists of 12,112,627 shares of the common stock held by Accelmed Growth Partners, L.P.  Uri Geiger is the controlling member and managing partner of Accelmed Growth Partners (AGP) Limited, which is the general partner of Accelmed Growth Partners (GP), L.P., which is the general partner of Accelmed Growth Partners, L.P. and as a result Uri Geiger may be deemed to beneficially own the shares of common stock held by Accelmed Growth Partners, L.P. Uri Geiger is the controlling shareholder and managing partner of Accelmed Growth Partners Management Ltd., which has certain voting and dispositive power over the 12,112,627 shares of common stock owned by Accelmed Growth Partners, L.P. pursuant to a management agreement, and as a result Uri Geiger may be deemed to beneficially own the shares of the common stock held by Accelmed Growth Partners, L.P."}],"balance_after":12122627,"source":{"system":"sec-edgar","filing":"0001567619-18-002345","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051514/000156761918002345/doc1.xml","form_type":"4"}},{"id":3898877,"issuer":{"id":72980,"kind":"organization","name":"STRATA Skin Sciences, Inc.","symbol":"SSKN"},"owners":[{"id":36322,"kind":"person","name":"Geiger Uri","position":1,"cik":"0001467361","reported_name":"Geiger Uri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"STRATA Restricted Stock Units","published_at":"2018-06-11T18:23:52.000Z","date":"2018-06-08","kind":"grant","acquired":true,"shares":19324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted Stock Options will vest 100%, in equal quarterly installments, over a 12 month period."}],"balance_after":19324,"derivative":{"exercise_price":2.07,"exercise_date":"2019-06-08","expiration_date":"2028-06-08","underlying":"Common Stock","underlying_shares":19324},"source":{"system":"sec-edgar","filing":"0001140361-18-028131","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051514/000114036118028131/doc1.xml","form_type":"4"}},{"id":3958847,"issuer":{"id":167360,"kind":"organization","name":"COGENTIX MEDICAL INC /DE/","symbol":"CGNT"},"owners":[{"id":36322,"kind":"person","name":"Geiger Uri","position":1,"cik":"0001467361","reported_name":"Geiger Uri","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-04-23T17:05:41.000Z","date":"2018-04-20","kind":"other","acquired":false,"shares":16129033,"price":3.85,"value":62096777.05,"ownership":{"direct":false,"nature":"See footnote 2"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 20, 2018, these shares were purchased in a tender offer for all of the issued and outstanding shares of common stock, par value $0.01 per share, of Cogentix Medical, Inc. (the Company\") by Camden Merger Sub, Inc. (\"Merger Sub\"), a wholly owned subsidiary of LM US Parent, Inc. and Laborie Medical Technologies Canada ULC, pursuant to the Agreement and Plan of Merger dated as of March 11, 2018 (the \"Merger Agreement\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Consists of 16,129,033 shares of the common stock held by Accelmed Growth Partners, L.P. Uri Geiger is the controlling member and managing partner of Accelmed Growth Partners (AGP) Limited, which is the general partner of Accelmed Growth Partners (GP), L.P., which is the general partner of Accelmed Growth Partners, L.P., and as a result Uri Geiger may be deemed to beneficially own the shares of common stock held by Accelmed Growth Partners, L.P. Uri Geiger is the controlling shareholder and managing partner of Accelmed Growth Partners Management Ltd., which has certain voting and dispositive power over the 16,129,033 shares of common stock owned by Accelmed Growth Partners, L.P. pursuant to a management agreement, and as a result Uri Geiger may be deemed to beneficially own the shares of the common stock held by Accelmed Growth Partners, L.P."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001437749-18-007486","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/894237/000143774918007486/rdgdoc.xml","form_type":"4"}}]}